TURK ILAC SERUM

The current price of TRILC is 22.82 TRY — it has increased by 2.06% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange TURK ILAC SERUM stocks are traded under the ticker TRILC.

TRILC stock is 3.20% volatile and has beta coefficient of 0.54. Check out the list of the most volatile stocks — is TURK ILAC SERUM there?

Yes, you can track TURK ILAC SERUM financials in yearly and quarterly reports right on TradingView.

TRILC stock has risen by 14.16% compared to the previous week, the month change is a 49.15% rise, over the last year TURK ILAC SERUM has showed a 132.86% increase.

TRILC net income for the last quarter is ‪23.34 M‬ TRY, while the quarter before that showed ‪46.64 M‬ TRY of net income which accounts for −49.96% change. Track more TURK ILAC SERUM financial stats to get the full picture.

No, TRILC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, TRILC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TURK ILAC SERUM stock right from TradingView charts — choose your broker and connect to your account.

TRILC reached its all-time high on Apr 2, 2021 with the price of 35.04 TRY, and its all-time low was 5.24 TRY and was reached on Mar 5, 2021.
See other stocks reaching their highest and lowest prices.

As of Apr 24, 2024, the company has 439.00 employees. See our rating of the largest employees — is TURK ILAC SERUM on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TURK ILAC SERUM technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TURK ILAC SERUM stock shows the strong buy signal. See more of TURK ILAC SERUM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TURK ILAC SERUM EBITDA is ‪302.49 M‬ TRY, and current EBITDA margin is 15.80%. See more stats in TURK ILAC SERUM financial statements.